文献速递心力衰竭与心肌病

循环肌钙蛋白浓度与老年人左室收缩及舒张功能及新发心衰的关联

Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
PubMed 文献 · JAMA Cardiol · 2019-01-01

该研究基于ARIC队列中4111名无心血管疾病的老年人,分析高敏肌钙蛋白T(hs-cTnT)与超声心动图左室收缩及舒张功能及新发心衰的关联。结果显示,hs-cTnT升高与左室质量指数增加及舒张功能恶化独立相关,但与收缩功能无关;舒张功能可解释hs-cTnT与新发射血分数保留心衰关联的41%。

要点

  • hs-cTnT升高与左室质量指数增加及舒张功能恶化独立相关,与收缩功能无关。
  • 舒张功能可解释hs-cTnT与射血分数保留心衰关联的41%。
  • hs-cTnT升高与舒张功能障碍对心衰发生具有相加风险。

核心结论

  • hs-cTnT浓度升高与更差的舒张功能相关,且独立于左室质量指数,但与收缩功能无关。
  • 高水平的hs-cTnT可能作为亚临床舒张功能改变的早期标志,从而易感心衰。

研究设计与样本

  • 基于ARIC前瞻性队列研究,纳入4111名无心血管疾病的参与者。
  • 女性2586名(62.9%),平均(SD)年龄75(5)岁。
  • hs-cTnT在访視5中位(IQR)浓度为9(7-14)ng/L,96.0%可检测到。

主要发现

  • 校正人口学和临床协变量后,hs-cTnT较高与左室质量指数较大相关(第1组校正均值[SE] 33.8[0.5] vs 第5组40.1[0.4];趋势P<.001)。
  • hs-cTnT较高与舒张功能较差相关:组织多普勒e'较低(6.00[0.07] vs 5.54[0.06];趋势P<.001),E/e'比值较高(11.4[0.2] vs 12.9[0.1];趋势P<.001),左房容积指数较大(23.4[0.4] vs 26.4[0.3];趋势P<.001),独立于左室质量指数。
  • hs-cTnT水平与左室收缩功能指标无关。
  • 校正舒张功能后,hs-cTnT与新发HFpEF的关联减弱41%,与射血分数中间值及降低心衰(LVEF<50%)合并的关联减弱17%。
  • hs-cTnT升高与舒张功能障碍对心衰发生具有相加风险;从中年到晚年可检测到hs-cTnT的持续时间越长,晚年左室质量越大,但与收缩或舒张功能无关。

临床怎么用

  • hs-cTnT可能作为早期识别亚临床舒张功能异常及心衰易感个体的标志物。
  • 在老年人群中,评估hs-cTnT有助于判断舒张功能相关心衰风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cardiac troponin is associated with incident heart failure and greater left ventricular (LV) mass. Its association with LV systolic and diastolic functions is unclear. OBJECTIVES: To define the association of high-sensitivity cardiac troponin T (hs-cTnT) with LV systolic and diastolic functions in the general population, and to evaluate the extent to which that association accounts for the correlation between hs-cTnT concentration and incident heart failure overall, heart failure with preserved LV ejection fraction (LVEF; HFpEF), and heart failure with LVEF less than 50%. DESIGN, SETTING, AND PARTICIPANTS: This analysis of the Atherosclerosis Risk in Communities (ARIC) Study, an ongoing epidemiologic cohort study in US communities, included participants without cardiovascular disease (n = 4111). Available hs-cTnT measurements for participants who attended ARIC Study visits 2 (1990 to 1992), 4 (1996 to 1998), and 5 (2011 to 2013) were assessed cross-sectionally against echocardiographic measurements taken at visit 5 and against incident health failure after visit 5. Changes in hs-cTnT concentrations from visits 2 and 4 were also examined. Data analyses were performed from August 2017 to July 2018. MAIN OUTCOMES AND MEASURES: Cardiac structure and function by echocardiography at visit 5, and incident heart failure during a median 4½ years follow-up after visit 5. RESULTS: Of the 6538 eligible participants, 4111 (62.9%) without cardiovascular disease were included. Among these participants, 2586 (62.9%) were female, and the mean (SD) age was 75 (5) years. Median (interquartile range) hs-cTnT concentration at visit 5 was 9 (7-14) ng/L and was detectable in 3946 participants (96.0%). After adjustment for demographic and clinical covariates, higher hs-cTnT levels were associated with greater LV mass index (adjusted mean [SE] for group 1: 33.8 [0.5] vs group 5: 40.1 [0.4]; P for trend < .001) and with worse diastolic function, including lower tissue Doppler imaging e' (6.00 [0.07] vs 5.54 [0.06]; P for trend < .001), higher E/e' ratio (11.4 [0.2] vs 12.9 [0.1]; P for trend < .001), and greater left atrial volume index (23.4 [0.4] vs 26.4 [0.3]; P for trend < .001), independent of LV mass index; hs-cTnT level was not associated with measures of LV systolic function. Accounting for diastolic function attenuated the association of hs-cTnT concentration with incident HFpEF by 41% and the association with combined heart failure with midrange and reduced ejection fraction combined (LVEF <50) by 17%. Elevated hs-cTnT concentration and diastolic dysfunction were additive risk factors for incident heart failure. For any value of late-life hs-cTnT levels, longer duration of detectable hs-cTnT from midlife to late life was associated with greater LV mass in late life but not with worse LV systolic or diastolic function. CONCLUSIONS AND RELEVANCE: This study shows that higher hs-cTnT concentrations were associated with worse diastolic function, irrespective of LV mass, but not with systolic function; these findings suggest that high levels of hs-cTnT may serve as an early marker of subclinical alterations in diastolic function that may lead to a predisposition to heart failure.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Myhre PL, Claggett B, Ballantyne CM, et al. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults. JAMA Cardiol. 2019. PMID: 31483438. doi:10.1001/jamacardio.2019.3113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。